HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Parlux Fragrances

This article was originally published in The Rose Sheet

Executive Summary

Parlux Fragrances: Appoints Jeffrey Dame, 36, to executive VP. Reporting to Chairman and CEO Ilia LeKach, Dame will "take a lead role" in future acquisitions, licensing agreements and new product development, Parlux said. During his time with the company, Dame has "played an integral part" in the company's expansion plans, including the 1994 Fred Hayman Beverly Hills and Perry Ellis acquisitions and the 1995 Alexandra de Markoff purchase, according to Parlux. For the past two years, he has held the position of senior VP-sales and marketing, and previously served as VP-sales and marketing. Dame's former responsibilities will be split into two positions -- one in sales and another in marketing...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS002847

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel